Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dolutegravir Monotherapy vs Triple Therapy Maintenance in HIV-1
NCT02596334Phase 3Terminated
- Sponsor
- Centre Hospitalier Régional d'Orléans
- Start
- Dec 2015
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dolutegravir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Centre Hospitalier Régional d'Orléans. Started Dec 2015; status: terminated.
02
Drugs
dolutegravir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT02596334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02596334.